Glenmark Life Sciences

1,077.85
-5.05
(-0.47%)
Market Cap (₹ Cr.)
₹13,283
52 Week High
1,335.10
Book Value
₹
52 Week Low
620.20
PE Ratio
31.37
PB Ratio
5.23
PE for Sector
37.21
PB for Sector
3.95
ROE
21.84 %
ROCE
26.24 %
Dividend Yield
2.08 %
EPS
₹36.48
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
4.80 %
Net Income Growth
0.84 %
Cash Flow Change
35.13 %
ROE
-7.55 %
ROCE
-8.31 %
EBITDA Margin (Avg.)
-2.44 %

Financial Results

Quarterly Financials
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
399
521
501
468
529
564
526
519
499
519
547
624
580
601
575
540
594
515
Expenses
259
394
345
297
364
394
376
372
343
366
395
415
385
428
400
395
429
373
EBITDA
140
127
155
170
164
169
150
147
156
154
152
209
195
172
174
145
165
143
Operating Profit %
35 %
24 %
31 %
36 %
31 %
30 %
28 %
28 %
30 %
28 %
27 %
33 %
33 %
28 %
30 %
26 %
27 %
27 %
Depreciation
8
8
8
8
9
10
10
10
10
10
11
12
13
13
13
15
14
15
Interest
23
22
22
21
21
7
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
108
97
125
141
135
153
140
138
146
144
141
198
182
159
161
130
150
127
Tax
25
23
30
35
32
37
32
37
36
34
33
47
44
39
39
31
38
30
Net Profit
81
72
93
105
101
115
104
99
109
107
105
146
135
119
119
98
111
95
EPS in ₹
7.52
6.72
8.66
9.71
9.36
9.83
8.65
8.07
8.87
8.72
8.57
11.94
11.05
9.69
9.69
7.99
9.10
7.78

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
0
1,475
1,726
1,997
2,471
2,702
2,850
Fixed Assets
0
456
546
573
590
781
805
Current Assets
0
931
1,160
1,399
1,765
1,850
1,916
Capital Work in Progress
0
80
11
14
97
62
106
Investments
0
0
0
0
0
0
0
Other Assets
0
939
1,169
1,410
1,784
1,860
1,939
Total Liabilities
1
1,387
1,324
1,244
417
564
518
Current Liabilities
1
1,380
1,307
1,221
384
497
439
Non Current Liabilities
0
7
16
23
33
67
79
Total Equity
-1
88
402
753
2,054
2,138
2,332
Reserve & Surplus
-1
86
400
751
2,030
2,114
2,308
Share Capital
0
2
2
2
25
25
25

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
2
8
106
397
-228
18
Investing Activities
0
-9
-51
-69
-122
-147
-116
Operating Activities
-0
10
195
388
598
306
414
Financing Activities
0
1
-137
-214
-79
-388
-279

Share Holding

% Holding
Apr 2021
Aug 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
100.00 %
82.84 %
82.84 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
75.00 %
FIIs
0.00 %
6.55 %
8.03 %
8.32 %
8.12 %
7.58 %
6.03 %
4.46 %
3.29 %
3.27 %
4.38 %
4.57 %
5.01 %
4.82 %
7.85 %
DIIs
0.00 %
1.49 %
0.46 %
0.47 %
0.56 %
0.79 %
0.81 %
0.09 %
0.00 %
0.58 %
0.64 %
0.74 %
1.40 %
1.57 %
4.16 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
9.11 %
8.67 %
8.36 %
8.47 %
8.78 %
10.31 %
12.60 %
13.86 %
13.30 %
12.12 %
11.84 %
10.73 %
10.76 %
12.98 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,764.50 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
1,456.95 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
2,537.10 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
1,194.45 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
941.70 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
2,038.30 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
1,221.55 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
5,553.10 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
1,462.55 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
1,568.75 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
49.46
ATR(14)
Less Volatile
54.05
STOCH(9,6)
Neutral
42.45
STOCH RSI(14)
Neutral
73.39
MACD(12,26)
Bullish
4.27
ADX(14)
Weak Trend
16.37
UO(9)
Bearish
48.71
ROC(12)
Uptrend But Slowing Down
5.40
WillR(14)
Neutral
-43.20